Substituted pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalines for inhibiting serotonin reuptake transporter activity
US9708322B2 · kind B2 · utility
68Cited by
17References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 15, 2014 |
| Grant date | Jul 18, 2017 |
| Priority date | — |
| Expiry date | Mar 15, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to substituted heterocycle fused gamma-carbolines of the Formula Q as described herein, in free base or pharmaceutically acceptable salt form, and/or pharmaceutical compositions thereof, and methods of use in the treatment of diseases involving the 5-HT2A receptor pathway, the serotonin transporter (SERT) pathway and/or the dopamine D2 receptor pathway signaling systems.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.